Cornucopian Capital is a venture capital firm based in Montclair, New Jersey, dedicated to advancing 'Medicine 3.0' — preventative, predictive, personalized, and participatory healthcare. The firm invests in companies enhancing healthspan, performance, and longevity across healthcare, biotech, consumer health, and food sectors, and also operates a venture studio/foundry model.
60% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $12.7M (across 5 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Handspring Health | Series B | $19M | Jul 2026 |
| Handspring Health | Series A | $12M | Jul 2025 |
| HHandspring | Series A | $12M | Jun 2025 |
 InsideTracker | Series B | $15M | Sep 2022 |
| IIlant Health | Seed | $5.5M | — |
Top Co-Investors
NextView Ventures2 shared
nvp capital2 shared
Cobalt Capital2 shared
OurCrowd1 shared
BASF Venture Capital1 shared
PeakBridge1 shared
HPA1 shared
25madison1 shared
Arkitekt Ventures1 shared
VamosVentures1 shared
Angelini Ventures1 shared
Celtic House Asia Partners1 shared
Last updated: 9 September 2026